Chemed Total Liabilities and Share Holders Equity 2010-2024 | CHE

Chemed total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Chemed total liabilities and share holders equity for the quarter ending September 30, 2024 was $1.769B, a 13.27% increase year-over-year.
  • Chemed total liabilities and share holders equity for 2023 was $1.668B, a 15.68% increase from 2022.
  • Chemed total liabilities and share holders equity for 2022 was $1.442B, a 7.39% increase from 2021.
  • Chemed total liabilities and share holders equity for 2021 was $1.343B, a 6.42% decline from 2020.
Chemed Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,668
2022 $1,442
2021 $1,343
2020 $1,435
2019 $1,268
2018 $976
2017 $920
2016 $880
2015 $852
2014 $860
2013 $894
2012 $860
2011 $796
2010 $830
2009 $819
Chemed Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $1,769
2024-06-30 $1,735
2024-03-31 $1,728
2023-12-31 $1,668
2023-09-30 $1,562
2023-06-30 $1,505
2023-03-31 $1,431
2022-12-31 $1,442
2022-09-30 $1,356
2022-06-30 $1,313
2022-03-31 $1,306
2021-12-31 $1,343
2021-09-30 $1,318
2021-06-30 $1,384
2021-03-31 $1,458
2020-12-31 $1,435
2020-09-30 $1,367
2020-06-30 $1,291
2020-03-31 $1,278
2019-12-31 $1,268
2019-09-30 $1,233
2019-06-30 $1,094
2019-03-31 $1,070
2018-12-31 $976
2018-09-30 $979
2018-06-30 $928
2018-03-31 $913
2017-12-31 $920
2017-09-30 $895
2017-06-30 $910
2017-03-31 $886
2016-12-31 $880
2016-09-30 $842
2016-06-30 $853
2016-03-31 $883
2015-12-31 $852
2015-09-30 $898
2015-06-30 $885
2015-03-31 $896
2014-12-31 $860
2014-09-30 $870
2014-06-30 $842
2014-03-31 $869
2013-12-31 $894
2013-09-30 $882
2013-06-30 $899
2013-03-31 $899
2012-12-31 $860
2012-09-30 $865
2012-06-30 $831
2012-03-31 $831
2011-12-31 $796
2011-09-30 $815
2011-06-30 $851
2011-03-31 $823
2010-12-31 $830
2010-09-30 $898
2010-06-30 $866
2010-03-31 $854
2009-12-31 $819
2009-09-30 $801
2009-06-30 $776
2009-03-31 $774
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.477B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
Quest Diagnostics (DGX) United States $18.293B 18.54
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
Amedisys (AMED) United States $2.953B 21.02
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Atai Life Sciences (ATAI) Germany $0.255B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00